載入中
NASDAQBasic MaterialsAgricultural Inputs
最新資料
US$0.2643
−US$0.0093 · -3.40%
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
前收盤價
US$0.2643
−US$0.0093 · -3.40%
盤中時間採用ET。市場資料可能有所延遲。
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
日內區間
目前US$0.2643
52週區間
目前US$0.2643
盤中時間採用ET。市場資料可能有所延遲。
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
日內區間
目前US$0.2643
52週區間
目前US$0.2643
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 485.8萬 USD | 504.5萬 USD | 445.4萬 USD | 741.8萬 USD | 678萬 USD |
| 銷貨成本 | 309.8萬 USD | 296.3萬 USD | 217.4萬 USD | 610.1萬 USD | 870.8萬 USD |
| 毛利 | 176萬 USD | 208.2萬 USD | 228萬 USD | 131.7萬 USD | −192.8萬 USD |
| 研究與開發 | 9000 USD | 5.3萬 USD | 6.4萬 USD | 150.9萬 USD | 388.9萬 USD |
| 銷售、一般及管理費用 | 700.1萬 USD | 964.1萬 USD | 823.4萬 USD | 1503.6萬 USD | 2293.8萬 USD |
| 營業費用 | 1175.5萬 USD | 573萬 USD | 838.2萬 USD | 1532.4萬 USD | 3359.8萬 USD |
| 利息收入 | 22.1萬 USD | 78.2萬 USD | 69.5萬 USD | 28.9萬 USD | — |
| 利息支出 | — | — | — | — | 2萬 USD |
| 折舊和攤銷 | 3.2萬 USD | 76.5萬 USD | 28.7萬 USD | 47.9萬 USD | 104.5萬 USD |
| 營業利益 | −999.5萬 USD | −364.8萬 USD | −610.2萬 USD | −1400.7萬 USD | −3552.6萬 USD |
| 淨利 | −233.9萬 USD | −703.8萬 USD | −1398.1萬 USD | −1537.6萬 USD | −1466萬 USD |
公司資料更新於 2026年10月11日。
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
